Annual Accounts Payable
$16.59 M
+$1.53 M+10.14%
December 31, 2024
Summary
- As of March 10, 2025, PACB annual accounts payable is $16.59 million, with the most recent change of +$1.53 million (+10.14%) on December 31, 2024.
- During the last 3 years, PACB annual accounts payable has risen by +$5.59 million (+50.79%).
- PACB annual accounts payable is now at all-time high.
Performance
PACB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$16.59 M
+$4.53 M+37.52%
December 31, 2024
Summary
- As of March 10, 2025, PACB quarterly accounts payable is $16.59 million, with the most recent change of +$4.53 million (+37.52%) on December 31, 2024.
- Over the past year, PACB quarterly accounts payable has increased by +$4.53 million (+37.52%).
- PACB quarterly accounts payable is now -21.02% below its all-time high of $21.01 million, reached on March 31, 2024.
Performance
PACB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PACB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.1% | +37.5% |
| 3 y3 years | +50.8% | +37.5% |
| 5 y5 years | +98.3% | +37.5% |
PACB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.8% | -21.0% | +50.8% |
| 5 y | 5-year | at high | +363.5% | -21.0% | +378.0% |
| alltime | all time | at high | +866.2% | -21.0% | +866.2% |
Pacific Biosciences Of California Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $16.59 M(+10.1%) | $16.59 M(+37.5%) |
| Sep 2024 | - | $12.06 M(-31.0%) |
| Jun 2024 | - | $17.49 M(-16.7%) |
| Mar 2024 | - | $21.01 M(+39.5%) |
| Dec 2023 | $15.06 M(+25.2%) | $15.06 M(-6.5%) |
| Sep 2023 | - | $16.11 M(-2.5%) |
| Jun 2023 | - | $16.51 M(-5.0%) |
| Mar 2023 | - | $17.39 M(+44.6%) |
| Dec 2022 | $12.03 M(+9.3%) | $12.03 M(-6.4%) |
| Sep 2022 | - | $12.85 M(-0.2%) |
| Jun 2022 | - | $12.88 M(-26.8%) |
| Mar 2022 | - | $17.61 M(+60.0%) |
| Dec 2021 | $11.00 M(+207.4%) | $11.00 M(+121.8%) |
| Sep 2021 | - | $4.96 M(+4.2%) |
| Jun 2021 | - | $4.76 M(+37.2%) |
| Mar 2021 | - | $3.47 M(-3.0%) |
| Dec 2020 | $3.58 M(-57.2%) | $3.58 M(-33.8%) |
| Sep 2020 | - | $5.41 M(-27.3%) |
| Jun 2020 | - | $7.44 M(+76.1%) |
| Mar 2020 | - | $4.22 M(-49.5%) |
| Dec 2019 | $8.37 M(+24.2%) | $8.37 M(+3.2%) |
| Sep 2019 | - | $8.11 M(+1.2%) |
| Jun 2019 | - | $8.01 M(-8.3%) |
| Mar 2019 | - | $8.74 M(+29.8%) |
| Dec 2018 | $6.74 M(-25.9%) | $6.74 M(+12.9%) |
| Sep 2018 | - | $5.97 M(+43.1%) |
| Jun 2018 | - | $4.17 M(-51.3%) |
| Mar 2018 | - | $8.57 M(-5.8%) |
| Dec 2017 | $9.09 M | $9.09 M(+6.1%) |
| Sep 2017 | - | $8.57 M(+31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $6.51 M(-20.8%) |
| Mar 2017 | - | $8.22 M(-1.7%) |
| Dec 2016 | $8.36 M(+76.0%) | $8.36 M(+0.6%) |
| Sep 2016 | - | $8.31 M(+54.1%) |
| Jun 2016 | - | $5.39 M(+14.0%) |
| Mar 2016 | - | $4.73 M(-0.3%) |
| Dec 2015 | $4.75 M(-15.3%) | $4.75 M(-22.1%) |
| Sep 2015 | - | $6.10 M(+4.8%) |
| Jun 2015 | - | $5.82 M(-16.0%) |
| Mar 2015 | - | $6.92 M(+23.5%) |
| Dec 2014 | $5.61 M(+226.6%) | $5.61 M(-4.1%) |
| Sep 2014 | - | $5.84 M(+8.7%) |
| Jun 2014 | - | $5.38 M(+37.0%) |
| Mar 2014 | - | $3.93 M(+128.7%) |
| Dec 2013 | $1.72 M(-42.5%) | $1.72 M(-49.7%) |
| Sep 2013 | - | $3.41 M(+31.0%) |
| Jun 2013 | - | $2.60 M(-13.5%) |
| Mar 2013 | - | $3.01 M(+0.8%) |
| Dec 2012 | $2.99 M(-37.0%) | $2.99 M(+3.1%) |
| Sep 2012 | - | $2.90 M(-28.7%) |
| Jun 2012 | - | $4.06 M(-4.4%) |
| Mar 2012 | - | $4.25 M(-10.4%) |
| Dec 2011 | $4.74 M(-50.2%) | $4.74 M(-41.9%) |
| Sep 2011 | - | $8.16 M(-9.7%) |
| Jun 2011 | - | $9.03 M(-4.2%) |
| Mar 2011 | - | $9.43 M(-0.9%) |
| Dec 2010 | $9.52 M(+64.7%) | $9.52 M(-28.0%) |
| Sep 2010 | - | $13.21 M(+73.5%) |
| Jun 2010 | - | $7.61 M(+31.8%) |
| Dec 2009 | $5.78 M(+213.2%) | $5.78 M |
| Dec 2008 | $1.84 M | - |
FAQ
- What is Pacific Biosciences of California annual accounts payable?
- What is the all time high annual accounts payable for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual accounts payable year-on-year change?
- What is Pacific Biosciences of California quarterly accounts payable?
- What is the all time high quarterly accounts payable for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly accounts payable year-on-year change?
What is Pacific Biosciences of California annual accounts payable?
The current annual accounts payable of PACB is $16.59 M
What is the all time high annual accounts payable for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual accounts payable is $16.59 M
What is Pacific Biosciences of California annual accounts payable year-on-year change?
Over the past year, PACB annual accounts payable has changed by +$1.53 M (+10.14%)
What is Pacific Biosciences of California quarterly accounts payable?
The current quarterly accounts payable of PACB is $16.59 M
What is the all time high quarterly accounts payable for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly accounts payable is $21.01 M
What is Pacific Biosciences of California quarterly accounts payable year-on-year change?
Over the past year, PACB quarterly accounts payable has changed by +$4.53 M (+37.52%)